Projects funded by the NCN

Characterization of anticancer activity of new synthetic alpha-methylene-delta lactones in cancer cell lines.

Call: SONATA 9 , Panel: NZ3

Principal investigator: dr hab. Katarzyna Anna Gach-Janczak

Uniwersytet Medyczny w Łodzi, Wydział Lekarski

Study of casein kinase CK2 inhibition mechanisms

Call: OPUS 1 , Panel: ST5

Principal investigator: prof. Maria Wanda Bretner

Politechnika Warszawska, Wydział Chemiczny

Novel DNA Minor Groove Helix Alkylating Agents - Design, Synthesis and Antitumor Activity Screening

Call: OPUS 1 , Panel: NZ4

Principal investigator: dr Adam Józef Mieczkowski

Instytut Biochemii i Biofizyki PAN

Enzymatic catalysis as a versatile tool for the synthesis of 1,3-dimethylxanthine derivatives with potential anticancer ...

Call: PRELUDIUM 7 , Panel: ST5

Principal investigator: dr Paweł Borowiecki

Politechnika Warszawska, Politechnika Warszawska

The study of synergistic inhibition of tumor cell proliferation by CK2 casein kinase inhibitors and inhibitors of thymid...

Call: OPUS 7 , Panel: NZ7

Principal investigator: prof. Maria Wanda Bretner

Politechnika Warszawska, Wydział Chemiczny

Interaction of a potential anticancer agent, 3-bromopyruvic acid, with normal and malignant cells

Call: OPUS 4 , Panel: NZ7

Principal investigator: prof. Grzegorz Bartosz

Uniwersytet Rzeszowski, Wydział Biologiczno-Rolniczy

Development of methods for the synthesis of flourinated isoselenocyanate sulforaphane analogs with expected improved ant...

Call: PRELUDIUM 3 , Panel: ST5

Principal investigator: Tomasz Paweł Cierpiał

Centrum Badań Molekularnych i Makromolekularnych PAN

The new benzanilide derivates as promising anticancer agents

Call: OPUS 1 , Panel: NZ4

Principal investigator: dr hab. Marek Arkadiusz Murias

Uniwersytet Medyczny im. Karola Marcinkowskiego w Poznaniu, Wydział Farmaceutyczny

Functional nanomaterials based on drug–lipid–ligands as targeted delivery systems for anticancer agents in lung adenocar...

Call: PRELUDIUM 24 , Panel: NZ7

Principal investigator: Piotr Paweł Szyk

Uniwersytet Medyczny im. Karola Marcinkowskiego w Poznaniu

Application of Griesbaum Co-ozonolysis in the Synthesis of Iron-Sensitive Conjugates of 1,2,4-Trioxolanes as Anticancer ...

Call: OPUS 29 , Panel: ST5

Principal investigator: prof. Adam Włodzimierz Huczyński

Uniwersytet im. Adama Mickiewicza w Poznaniu

FA-PROTACs - Design and Synthesis of Compounds Based on Folic Acid for Degradation of Enzyme Involved in Folate Metaboli...

Call: SONATA 20 , Panel: NZ5

Principal investigator: dr Mateusz Daśko

Politechnika Gdańska

The two are better than one - biferrocenyl ROS generators as intelligent anticancer agents

Call: OPUS 27 , Panel: ST5

Principal investigator: prof. Konrad Maciej Kowalski

Uniwersytet Łódzki

Three to tango - biomaterials with therapeutic and regenerative multifunctionality

Call: SONATA BIS 13 , Panel: ST11

Principal investigator: dr Marzena Krystyna Fandzloch

Instytut Niskich Temperatur i Badań Strukturalnych im. Włodzimierza Trzebiatowskiego PAN

In vitro anticancer screening of triterpene saponins isolated from beetroot (Beta vulgaris L.) by countercurrent chromat...

Call: PRELUDIUM 22 , Panel: NZ9

Principal investigator: Anna Maria Tekieli

Politechnika Krakowska im. Tadeusza Kościuszki, Wydział Inżynierii i Technologii Chemicznej

Chiral hybrids of quinones and quinols with double anticancer and antimicrobial activity against drug-resistant pathogen...

Call: OPUS 25 , Panel: NZ7

Principal investigator: prof. Ryszard Józef Ostaszewski

Instytut Chemii Organicznej Polska Akademia Nauk

Design, Synthesis and Characterization of Functionalized 1,2,4-Trioxanes/Trioxepanes for Antimalarial and Anticancer Use

Call: SONATINA 7 , Panel: NZ7

Principal investigator: dr Mohit Kumar Tiwari

Uniwersytet Medyczny im. Karola Marcinkowskiego w Poznaniu

CHIRAL RHENIUM AND RHODIUM COMPLEXES OF ANTICANCER AND ANTIBACTERIAL ACTIVITY: SYNTHESIS, ACTIVITY, AND PHYSICOCHEMICAL ...

Call: OPUS 24 , Panel: NZ7

Principal investigator: prof. Jan Czesław Dobrowolski

Narodowy Instytut Leków

Heterocyclization of benzenoid ansamycins core as useful strategy for designing anticancer agents

Call: PRELUDIUM 20 , Panel: ST4

Principal investigator: Natalia Anna Skrzypczak

Uniwersytet im. Adama Mickiewicza w Poznaniu, Wydział Chemii

Mitochondria-targeting conjugates as a new anticancer agents

Call: OPUS 21 , Panel: ST4

Principal investigator: prof. Adam Włodzimierz Huczyński

Uniwersytet im. Adama Mickiewicza w Poznaniu, Wydział Chemii

Thrombin binding aptamer with expanded chemical diversity as potential anticoagulant and anticancer agent

Call: OPUS 21 , Panel: NZ7

Principal investigator: dr Weronika Paulina Kotkowiak

Instytut Chemii Bioorganicznej PAN

Novel bispecific G-quadruplex conjugates as potential anticancer agents

Call: PRELUDIUM 18 , Panel: NZ7

Principal investigator: dr Carolina Sofia Pereira Roxo

Instytut Chemii Bioorganicznej PAN

STING protein activation combined with anti-vascular agent as a novel strategy for anticancer therapy

Call: OPUS 16 , Panel: NZ5

Principal investigator: dr hab. Ryszard Smolarczyk

Centrum Onkologii - Instytut im. Marii Skłodowskiej-Curie, Oddział w Gliwicach

Dual ionophores as multitarget agents against pancreatic cancer

Call: OPUS 16 , Panel: NZ7

Principal investigator: dr hab. Robert Musioł

UNIWERSYTET ŚLĄSKI, Wydział Matematyki, Fizyki i Chemii

Novel human topoisomerase II inhibitors as anticancer agents

Call: PRELUDIUM 15 , Panel: NZ7

Principal investigator: dr Barbara Kaproń

Uniwersytet Medyczny w Lublinie, Wydział Nauk o Zdrowiu

Chemical modifications of macrocyclic polyketide -geldanamycin opening an access to new alternative anticancer agents in...

Call: OPUS 13 , Panel: ST5

Principal investigator: prof. Piotr Przybylski

Uniwersytet im. Adama Mickiewicza w Poznaniu, Wydział Chemii

Synthesis of new glutamate receptors antagonists and extensive investigation of their effect on tumor cells in the prese...

Call: OPUS 9 , Panel: ST5

Principal investigator: prof. Maria Wanda Bretner

Politechnika Warszawska, Wydział Chemiczny

Biocompatible polymeric nanocapsules as anticancer drug delivery system

Call: PRELUDIUM 9 , Panel: ST5

Principal investigator: dr Joanna Monika Szafraniec

Uniwersytet Jagielloński, Wydział Chemii